Next Generation Advanced Insulin Delivery System in Adults With Diabetes and Advanced Renal Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 18, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
DialysisChronic Kidney DiseaseDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1HemodialysisPeritoneal Dialysis
Interventions
DEVICE

2nd Generation Automated Insulin Delivery (AID) system

The AID system will initially commence delivery by insulin pump post-randomisation without the AID in operation and with predictive low glucose suspend activated for a period of two weeks. Once safety has been established, the autocorrect function can be activated and the setpoint reduced to 5.5 mmol/L. Throughout the study insulin pump uploads will be reviewed twice weekly initially and at least weekly thereafter.

Trial Locations (1)

2100

Tobias Bomholt, Copenhagen

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

lead

Steno Diabetes Center Copenhagen

OTHER